pixnio-drone

Autonomous drone successfully delivers temperature-controlled drugs in test programme

pharmafile | July 17, 2019 | News story | Research and Development, Sales and Marketing Drones, humanitarian aid, pharma 

A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned aerial vehicles (UAVs).

Direct Relief announced that its fourth proof-of-concept mission testing the technology was a success, with an operator flying a UAV over open water between the islands of the Bahamas and out of line of sight. The test was conducted fully autonomously using cold-chain delivery technology, capable of transporting medicines and vaccines at temperatures as low as -70°C.

During the test, temperature of the cargo was tracked and monitored throughout in real-time via cloud technology. The project could mean a huge step forward in tackling the challenges of delivering medicines to hard-to-reach areas of the world and aid in humanitarian health efforts.

“Experience and research consistently show that those most at risk of health crisis in disasters live in communities which are likely to be cut off from essential health care due to disruption of transportation and communications,” said Andrew Schroeder, who leads analytics programmes, data visualisation, and geospatial analytics for Direct Relief. “Drone delivery is one of the most promising answers to this problem. More remains to be done to operationalise medical cargo drones in emergencies. But successful tests like this one demonstrate that remarkable new humanitarian capabilities are emerging quickly.”

Advertisement

The organisation now hopes to push the pilot programme onto testing in Africa and Latin America.

Matt Fellows

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content